Armistice Capital, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$5.62B
Q ending 2026-03-31
Prior quarter
$8.40B
Q ending 2025-12-31
Change
-33.1% QoQ · -15.7% YoY
Positions
261
reported holdings
Largest positions
Top 100 of 261 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| State Str Spdr S&P 500 Etf T | SPY | Put | $1.37B | 2.1M |
| Ishares Tr | IWM | Put | $868.0M | 3.5M |
| Travere Therapeutics Inc | TVTX | Shares | $145.5M | 4.9M |
| Ptc Therapeutics Inc | PTCT | Shares | $141.3M | 2.1M |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $138.5M | 265K |
| Cytokinetics Inc | CYTK | Call | $112.0M | 1.7M |
| Agios Pharmaceuticals Inc | AGIO | Call | $108.3M | 3.2M |
| Supernus Pharmaceuticals | SUPN | Shares | $98.0M | 1.9M |
| Neurocrine Biosciences Inc | NBIX | Shares | $95.4M | 724K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $91.9M | 2.7M |
| Immunovant Inc | IMVT | Shares | $88.6M | 3.6M |
| Freshpet Inc | FRPT | Shares | $64.5M | 1.1M |
| Incyte Corp | INCY | Shares | $61.8M | 657K |
| Dyne Therapeutics Inc | DYN | Shares | $57.6M | 3.2M |
| Amazon Com Inc | AMZN | Shares | $54.6M | 262K |
| Ironwood Pharmaceuticals Inc | IRWD | Shares | $52.7M | 15.0M |
| Cytokinetics Inc | CYTK | Shares | $50.4M | 765K |
| Immunovant Inc | IMVT | Call | $47.2M | 1.9M |
| Harmony Biosciences Hldgs In | HRMY | Shares | $45.5M | 1.6M |
| Thermo Fisher Scientific Inc | TMO | Shares | $45.0M | 91K |
| Nektar Therapeutics | NKTR | Shares | $41.6M | 578K |
| Unitedhealth Group Inc | UNH | Shares | $40.0M | 148K |
| Uber Technologies Inc | UBER | Shares | $37.3M | 519K |
| Immunocore Hldgs Plc | IMCR | Shares | $35.8M | 1.2M |
| Dentsply Sirona Inc | XRAY | Shares | $34.8M | 3.0M |
| Rigel Pharmaceuticals Inc | RIGL | Shares | $34.6M | 1.3M |
| Disc Medicine Inc | IRON | Shares | $34.3M | 536K |
| Alphabet Inc | GOOGL | Shares | $34.1M | 119K |
| Mineralys Therapeutics Inc | MLYS | Shares | $31.9M | 1.2M |
| Hubspot Inc | HUBS | Shares | $31.4M | 129K |
| Axogen Inc | AXGN | Shares | $31.0M | 936K |
| Orthofix Med Inc | OFIX | Shares | $31.0M | 2.7M |
| Kura Oncology Inc | KURA | Shares | $30.4M | 3.7M |
| Avanos Med Inc | AVNS | Shares | $28.0M | 2.0M |
| Regeneron Pharmaceuticals | REGN | Shares | $27.9M | 36K |
| Align Technology Inc | ALGN | Shares | $27.1M | 158K |
| Ptc Therapeutics Inc | PTCT | Call | $26.6M | 390K |
| Mongodb Inc | MDB | Shares | $26.3M | 107K |
| Alibaba Group Hldg Ltd | BABA | Shares | $25.6M | 204K |
| Medline Inc | MDLN | Shares | $25.1M | 565K |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $24.9M | 1.2M |
| Datadog Inc | DDOG | Shares | $24.6M | 209K |
| Humana Inc | HUM | Shares | $24.5M | 141K |
| Sentinelone Inc | S | Shares | $24.4M | 1.9M |
| Verastem Inc | VSTM | Shares | $24.3M | 4.6M |
| Five9 Inc | FIVN | Shares | $24.2M | 1.6M |
| Intuitive Surgical Inc | ISRG | Shares | $24.0M | 52K |
| Grifols S A | GRFS | Shares | $24.0M | 3.0M |
| Penn Entertainment Inc | PENN | Shares | $23.7M | 1.6M |
| Solid Biosciences Inc | SLDB | Shares | $23.0M | 3.2M |
| Gitlab Inc | GTLB | Shares | $22.3M | 1.0M |
| Autolus Therapeutics Ltd | AUTL | Shares | $21.8M | 15.8M |
| Sentinelone Inc | S | Call | $21.3M | 1.6M |
| Angiodynamics Inc | ANGO | Shares | $21.3M | 1.9M |
| Arvinas Inc | ARVN | Shares | $21.0M | 2.0M |
| Taiwan Semiconductor Manufac | TSM | Shares | $20.7M | 61K |
| Alto Neuroscience Inc | ANRO | Shares | $20.5M | 912K |
| Energizer Hldgs Inc | ENR | Shares | $19.7M | 1.2M |
| Five9 Inc | FIVN | Call | $19.0M | 1.3M |
| Meta Platforms Inc | META | Shares | $18.6M | 33K |
| 4D Molecular Therapeutics In | FDMT | Shares | $18.6M | 2.0M |
| Microsoft Corp | MSFT | Shares | $18.1M | 49K |
| Edwards Lifesciences Corp | EW | Shares | $18.0M | 225K |
| Wynn Resorts Ltd | WYNN | Shares | $17.6M | 174K |
| Macrogenics Inc | MGNX | Shares | $17.4M | 6.0M |
| Scholar Rock Hldg Corp | SRRK | Shares | $16.6M | 337K |
| Bicycle Therapeutics Plc | BCYC | Shares | $15.8M | 3.4M |
| Central Garden & Pet Co | CENTA | Shares | $15.5M | 478K |
| Lennar Corp | LEN | Shares | $15.4M | 177K |
| Toast Inc | TOST | Shares | $15.3M | 577K |
| Sanofi Sa | SNY | Shares | $14.5M | 300K |
| Bill Holdings Inc | BILL | Shares | $14.4M | 375K |
| Uipath Inc | PATH | Shares | $14.3M | 1.3M |
| Penn Entertainment Inc | PENN | Call | $13.5M | 900K |
| Voyager Therapeutics Inc | VYGR | Shares | $13.5M | 3.5M |
| Cytokinetics Inc | CYTK | Put | $13.2M | 200K |
| Gsk Plc | GSK | Shares | $13.0M | 236K |
| Teradyne Inc | TER | Shares | $13.0M | 44K |
| Crocs Inc | CROX | Shares | $12.8M | 155K |
| Nike Inc | NKE | Shares | $12.5M | 237K |
| Bristol-Myers Squibb Co | BMY | Shares | $12.4M | 205K |
| Vera Therapeutics Inc | VERA | Shares | $12.0M | 298K |
| Bridgebio Oncology Therapeut | BBOT | Shares | $11.9M | 1.3M |
| Capri Holdings Limited | Shares | $11.6M | 658K | |
| Nebius Group N.V. | Shares | $11.2M | 108K | |
| Xeris Biopharma Holdings Inc | XERS | Shares | $11.1M | 1.9M |
| Esperion Therapeutics Inc Ne | Shares | $10.8M | 3.9M | |
| Iqvia Hldgs Inc | IQV | Shares | $10.4M | 61K |
| Ross Stores Inc | ROST | Shares | $10.4M | 48K |
| Nvidia Corporation | NVDA | Shares | $10.3M | 59K |
| Sangamo Therapeutics Inc | SGMOQ | Shares | $10.0M | 40.4M |
| Intel Corp | INTC | Shares | $9.9M | 224K |
| Applovin Corp | APP | Shares | $9.7M | 24K |
| Workday Inc | WDAY | Shares | $9.6M | 74K |
| Reddit Inc | RDDT | Shares | $9.4M | 70K |
| Neuropace Inc | NPCE | Shares | $9.1M | 692K |
| Zura Bio Ltd | Shares | $9.0M | 1.5M | |
| Pegasystems Inc | PEGA | Shares | $9.0M | 210K |
| Generac Hldgs Inc | GNRC | Shares | $8.8M | 45K |
| Treace Med Concepts Inc | TMCI | Shares | $8.5M | 6.4M |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.